A preclinical model of TB meningitis to determine drug penetration and activity at the sites of disease is a research paper published in Antimicrobial Agents and Chemotherapy (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: R01 AI145436
NIAID NIH HHS
Grant: U01 AI170426
The Francis Crick Institute
Grant: CC2112
The Francis Crick Institute
Grant: CC1109
FIC NIH HHS
Grant: K43 TW011421
National Institutes of Health
Grant: 1K43TW011421-01
Characterizing the pharmacokinetics of high dose rifampicin and linezolid in a randomized controlled trial for HIV-associated tuberculous meningitis
National Institutes of Health
Grant: 5R01AI145436-02
Translational approaches to improve understanding and outcome in Tuberculous meningitis
Wellcome Trust
Grant: 203135
Centre for Infectious Diseases Research in Africa (CIDRI-Africa)
National Institutes of Health
Grant: 3U01AI170426-04S2
PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis
FWCI
1.27
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals